Significant adverse events, including concerning palpitations or arrhythmias potentially related to semaglutide, should be reported to the FDA MedWatch program to enhance post-marketing safety surveillance
Supply : In 2025, supply bottlenecks will continue to ease following extensive efforts by Novo Nordisk and Lilly to step up manufacturing, with important implications for competitive dynamics: The large-scale opportunity for compounders will be closing
Is Ozempic licensed for weight loss in the UK
Patients should be counseled that scale weight may not accurately reflect body composition changes
The findings underscore what multiple analyses of real-world use of the so-called GLP-1 medicines, as well as studies in animals, had already hinted at: Ozempic and similar drugs, already incredibly popular, could help reduce risks of overconsuming alcohol, if the results bear out in larger and longer trials